Assessing the effects of probiotic supplementation in patients with metastatic melanoma on checkpoint-inhibitor therapy

被引：0
|
作者：
Vujevic, Andro [1 ]
Strikic, Dominik [1 ]
Plese, Sven [1 ]
Cegec, Ivana [1 ]
Turk, Viktorija Erdeljic [1 ]
Ausperger, Ksenija Makar [1 ]
Mikulic, Iva [1 ]
Aumiler, Matea Radacic [1 ]
Likic, Robert [1 ]
Mercep, Iveta [1 ]
机构：
[1] Univ Hosp Ctr Zagreb, Zagreb, Croatia
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2023年 / 180卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P0926
引用
收藏
页码：382 / 382
页数：1
相关论文
共 50 条
  • [31] Evaluation of psychosocial factors concerning the management of side effects of oncological patients undergoing checkpoint-inhibitor immunotherapy
    Strauch, N.
    Missalla, I.
    Goerling, U.
    Mieville, H.
    Keller, U.
    Letsch, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 117 - 117
  • [32] TIME TO DIAGNOSTIC CLARITY FOR SUSPECTED CHECKPOINT-INHIBITOR PNEUMONITIS IN PATIENTS WITH LUNG CANCER
    Olson, Eric
    Faucheux, Andrew
    Liang, JiaHao
    Ponnatapura, Janardhana
    Lantz, Jeffrey
    Roberts, Nathan
    Dothard, Andy
    Lycan, Thomas
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A394 - A394
  • [33] Additional Benefit of FDG-PET when Discontinuing Immune Checkpoint Inhibitor Therapy in Patients with metastatic Melanoma
    Zaremba, A.
    Ferdinandus, J.
    Zimmer, L.
    Umutlu, L.
    Seifert, R.
    Barbato, F.
    Ugurel, S.
    Chorti, E.
    Gruenwald, V.
    Herrman, K.
    Schadendorf, D.
    Fendler, W. P.
    Livingstone, E.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 75 - 76
  • [34] Acute renal allograft rejection after immune checkpoint inhibitor therapy for metastatic melanoma
    Spain, L.
    Higgins, R.
    Gopalakrishnan, K.
    Turajlic, S.
    Gore, M.
    Larkin, J.
    ANNALS OF ONCOLOGY, 2016, 27 (06) : 1135 - 1137
  • [35] Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients
    Omar Hasan Ali
    Fiamma Berner
    Christoph Jakob Ackermann
    Sandra Stephanie Ring
    Alexandre Moulin
    Joachim Müller
    Eva Markert
    Oltin Tiberiu Pop
    Stefanie Müller
    Stefan Diem
    Thomas Hundsberger
    Lukas Flatz
    Cancer Immunology, Immunotherapy, 2021, 70 : 563 - 568
  • [36] Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients
    Ali, Omar Hasan
    Berner, Fiamma
    Ackermann, Christoph Jakob
    Ring, Sandra Stephanie
    Moulin, Alexandre
    Mueller, Joachim
    Markert, Eva
    Pop, Oltin Tiberiu
    Mueller, Stefanie
    Diem, Stefan
    Hundsberger, Thomas
    Flatz, Lukas
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (02) : 563 - 568
  • [37] Immune Checkpoint Inhibitor Therapy: A Boon to Elderly Patients with Advanced Melanoma?
    Muta, Tsuyoshi
    INTERNAL MEDICINE, 2018, 57 (16) : 2287 - 2288
  • [38] Rate of response to immune checkpoint inhibitor therapy in patients with conjunctival melanoma
    Esmaeli, Bita
    Ogden, Tyler
    Nichols, Matthew
    Lu, Tracy
    Debnam, J. Matthew
    Dimitriou, Florentia
    Mcquade, Jennifer
    Oliva, Isabella C. Glitza
    MELANOMA RESEARCH, 2025, 35 (02) : 130 - 144
  • [39] Progress in Immune Checkpoint Inhibitor for Melanoma Therapy
    Boutros, Celine
    Herrscher, Hugo
    Robert, Caroline
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2024, 38 (05) : 997 - 1010
  • [40] Metabolomic signatures in liquid biopsy are associated with overall survival in metastatic melanoma patients treated with immune checkpoint inhibitor therapy
    Susan Costantini
    Gabriele Madonna
    Mariaelena Capone
    Elena Di Gennaro
    Palmina Bagnara
    Federica Renza
    Domenico Mallardo
    Roberta Affatato
    Carlo Vitagliano
    Marilena Romanelli
    Marilena Tuffanelli
    Ester Simeone
    Gennaro Ciliberto
    Paolo A. Ascierto
    Alfredo Budillon
    Journal of Experimental & Clinical Cancer Research, 44 (1)
12345